STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
246
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $0 priced
What the filings say about SMG
Insiders, 180 days
-$2.2M net sold
3 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$2.2M
3 notices
Scotts Miracle-gro insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SCOTTS MIRACLE-GRO CO insiders sold a net $2.2M of stock across 108 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 7.7% of the 10,827 shares held after it.
2 other insiders sold within 30 days.
246 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Kingdon Mark D sold about $51.2K of SMG on Aug 10, 2026; 2 other insiders sold within 30 days and 246 funds added in the latest 13F quarter.
26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on Feb 12, 2026.
The trade is 0.2% of the 13,138,848 shares held after it.
2 other insiders sold within 30 days.
246 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hagedorn Partnership, L.P. sold about $1.9M of SMG on Aug 3, 2026; 2 other insiders sold within 30 days and 246 funds added in the latest 13F quarter.
26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on Feb 12, 2026.
The trade is 0.0% of the 13,137,641 shares held after it.
2 other insiders sold within 30 days.
246 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hagedorn Partnership, L.P. sold about $82.3K of SMG on Aug 3, 2026; 2 other insiders sold within 30 days and 246 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 1, 2024.
The trade is 3.9% of the 30,179 shares held after it.
2 other insiders sold within 30 days.
246 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Johnson Stephen L sold about $80.0K of SMG on Jul 30, 2026; 2 other insiders sold within 30 days and 246 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SMG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Kingdon Mark D
Filed 2026-08-10
$51.2K
Hagedorn Partnership, LP
Filed 2026-08-03
$2.0M
Johnson Stephen L
Filed 2026-07-30
$80.0K
SMG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Madison Small Cap Fund
$5.9M position · as of 2026-07-31
3.8%
Select Chemicals Portfolio
$16.7M position · as of 2026-05-31
3.8%
Ariel Fund
$96.1M position · as of 2026-06-30
3.3%
ICON Natural Resources and Infrastructure Fund
$4.3M position · as of 2026-06-30
3.2%
Sound Equity Dividend Income ETF
$809.1K position · as of 2026-05-31
2.8%
Brandes Small Cap Value Fund
$17.4M position · as of 2026-06-30
2.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
The Scotts Miracle-Gro Co Stewardship Pac
Cycle 2026 · $18K spent
$31.2K
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · James Hagedorn
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$12.3M
-$9.3M
$3.5M
-56%
+17%
2024
$15.2M
$35.8M
$4.4M
-36%
+33%
2023
$12.0M
$6.8M
$4.0M
-63%
+6%
2022
$8.2M
-$3.4M
$1.9M
-71%
-8%
2021
$10.7M
$8.2M
$2.8M
-3%
-0%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.2M sold by insiders over 180 days, 246 funds added last quarter, $2.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.4B
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM SMG
FY Sep 2025
$3.4B
FY Sep 2024
$3.6B
FY Sep 2023
$3.6B
FY Sep 2022
$3.9B
FY Sep 2021
$4.9B
Jun 2026
$1.2B
Mar 2026
$1.5B
Dec 2025
$354.4M
Sep 2025
$387.3M
Jun 2025
$1.2B
Mar 2025
$1.4B
Dec 2024
$416.8M
Sep 2024
$414.7M
At each fiscal year end
Single quarter
Net margin, TTM
+2.2%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM SMG
FY Sep 2025
+4.3%
FY Sep 2024
-1.0%
FY Sep 2023
-10.7%
FY Sep 2022
-11.1%
FY Sep 2021
+10.4%
Jun 2026
+9.6%
Mar 2026
+16.3%
Dec 2025
-35.3%
Sep 2025
-39.2%
Jun 2025
+12.6%
Mar 2025
+15.3%
Dec 2024
-16.7%
Sep 2024
-58.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$263.3M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM SMG
FY Sep 2025
$273.9M
FY Sep 2024
$583.5M
FY Sep 2023
$438.2M
FY Sep 2022
-$242.5M
FY Sep 2021
$164.6M
Jun 2026
$321.1M
Mar 2026
$201.4M
Dec 2025
-$390.4M
Sep 2025
$131.2M
Jun 2025
$437.5M
Mar 2025
$179.8M
Dec 2024
-$474.6M
Sep 2024
$101.9M
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity SMG
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
20.11x
FY Sep 2021
2.26x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.17x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-06-27
Cash flow to debt SMG
FY Sep 2025
0.18x
FY Sep 2024
0.30x
FY Sep 2023
0.20x
FY Sep 2022
-0.04x
FY Sep 2021
0.12x
Jun 2026
0.17x
Mar 2026
0.20x
Dec 2025
0.18x
Sep 2025
0.18x
Jun 2025
0.14x
Mar 2025
0.18x
Dec 2024
0.21x
Sep 2024
0.30x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity SMG
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
-75.3%
FY Sep 2021
+59.9%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.4%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets SMG
FY Sep 2025
+5.2%
FY Sep 2024
-1.1%
FY Sep 2023
-9.9%
FY Sep 2022
-9.6%
FY Sep 2021
+12.5%
Jun 2026
+2.4%
Mar 2026
+3.2%
Dec 2025
+2.9%
Sep 2025
+5.2%
Jun 2025
+1.6%
Mar 2025
+1.0%
Dec 2024
-0.7%
Sep 2024
-1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.6%
operating income after a 37.9% effective tax rate, over long-term 2026-06-27 plus current 2026-06-27 plus average of 2025-06-28 and 2026-06-27 minus cash
Return on invested capital SMG
FY Sep 2025
+14.0%
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
+18.3%
Jun 2026
+12.6%
Mar 2026
+14.2%
Dec 2025
+12.3%
Sep 2025
+14.0%
Jun 2025
+9.2%
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+17.6%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed SMG
FY Sep 2025
+17.4%
FY Sep 2024
+8.8%
FY Sep 2023
-5.8%
FY Sep 2022
-12.4%
FY Sep 2021
+23.7%
Jun 2026
+17.6%
Mar 2026
+18.7%
Dec 2025
+16.7%
Sep 2025
+17.4%
Jun 2025
+12.6%
Mar 2025
+10.7%
Dec 2024
+7.7%
Sep 2024
+8.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
49.86x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing SMG
FY Sep 2025
23.24x
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
16.35x
Jun 2026
59.25x
Mar 2026
33.32x
Dec 2025
38.62x
Sep 2025
23.24x
Jun 2025
82.17x
Mar 2025
101.41x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$5.5B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-27 plus current 2026-06-27, minus cash 2026-06-27
Enterprise value SMG
FY Sep 2025
$5.4B
FY Sep 2024
$7.1B
FY Sep 2023
$5.5B
FY Sep 2022
$5.3B
FY Sep 2021
$10.2B
Jun 2026
$6.2B
Mar 2026
$5.9B
Dec 2025
$5.9B
Sep 2025
$5.4B
Jun 2025
$5.9B
Mar 2025
$5.7B
Dec 2024
$6.5B
Sep 2024
$7.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield SMG
FY Sep 2025
+8.3%
FY Sep 2024
+11.8%
FY Sep 2023
+15.1%
FY Sep 2022
-10.2%
FY Sep 2021
+2.0%
Jun 2026
+6.5%
Mar 2026
+10.8%
Dec 2025
+10.7%
Sep 2025
+8.3%
Jun 2025
+6.4%
Mar 2025
+12.1%
Dec 2024
+12.9%
Sep 2024
+11.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.05x
P/E over trailing EPS growth of 47%: four quarters to 2026-06-27 against the four to 2025-06-28
PEG, trailing SMG
FY Sep 2025
n/a
FY Sep 2024
n/a
FY Sep 2023
n/a
FY Sep 2022
n/a
FY Sep 2021
0.52x
Jun 2026
1.25x
Mar 2026
0.14x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SMG ranks highest on institutional and government (73rd percentile) and profitability (68th), and lowest on insider conviction (11th), among Materials peers.
Profitability
68
Inputs
Return on equityaverage equity is zero or negative
Return on assets+2.4% · 55 pct, sector of 120
Return on invested capital+12.6% · 67 pct, sector of 37
Return on capital employed+17.6% · 81 pct, sector of 96
Financial health
47
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt0.17x · 47 pct, sector of 103
Growth
31
Inputs
Revenue growth, YoY-3.9% · 31 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
11
Inputs
Net Form 4 buying (codes P and S), 180d-$2.2M · 23 pct, sector of 80
Insider buyers, 180d0 · 0 pct, sector of 80
Institutional and government
73
Inputs
Funds adding, latest quarter246 · 77 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$660K · 69 pct, sector of 40
Risk and compliance
47
Inputs
Short interest, % of float+12.8% · 10 pct, sector of 145
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+15.3% · 32 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SMG filings, in plain words
Are Scotts Miracle-gro insiders buying or selling SMG?
In the 180 days to 2026-10-28, Scotts Miracle-gro insiders were net sellers, a net $2.2M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of SMG?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $2.2M of stock; the latest, by Kingdon Mark D, was filed 2026-08-10.
Read the full summary
In the 180 days to 2026-10-28, Scotts Miracle-gro insiders were net sellers of SMG, a net $2.2M across purchases and sales reported on Form 4 by 3 sellers. Most of that figure, $2.0M, came from a holder of 10% or more rather than an officer or director. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $2.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.